Clinical Trial Update: Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on continuing treatment for subjects who participated in a prior protocol investigating dasatinib; results posted after completion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Multiple Indications Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-05-06